Global Circulating Tumor Cell Testing Market Research Report 2025

Publication ID:

PB504252439

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Circulating Tumor Cell Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Circulating Tumor Cell Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Circulating Tumor Cell Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Circulating Tumor Cell Testing in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Circulating Tumor Cell Testing include Advanced Cell Diagnostics, Inc., Aviva Biosciences, Cynvenio Biosystems, Inc., ApoCell, Biocept Inc., Qiagen, MiltenyiBiotec, Clearbridge Biomedics Pte Ltd, Menarini Silicon Biosystems, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell Testing.
The Circulating Tumor Cell Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cell Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cell Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advanced Cell Diagnostics, Inc.
Aviva Biosciences
Cynvenio Biosystems, Inc.
ApoCell
Biocept Inc.
Qiagen
MiltenyiBiotec
Clearbridge Biomedics Pte Ltd
Menarini Silicon Biosystems
Segment by Type
Lmmunocytochemical Technology for Circulating Tumor Cell Testing
Molecular(rna) Based Technology for Circulating Tumor Cell Testing
Xenotransplantation Technology for Circulating Tumor Cell Testing
Others
Segment by Application
Hospital
Biological Testing Agency
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cell Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Lmmunocytochemical Technology for Circulating Tumor Cell Testing
1.2.3 Molecular(rna) Based Technology for Circulating Tumor Cell Testing
1.2.4 Xenotransplantation Technology for Circulating Tumor Cell Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Biological Testing Agency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell Testing Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cell Testing Growth Trends by Region
2.2.1 Global Circulating Tumor Cell Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cell Testing Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cell Testing Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cell Testing Market Dynamics
2.3.1 Circulating Tumor Cell Testing Industry Trends
2.3.2 Circulating Tumor Cell Testing Market Drivers
2.3.3 Circulating Tumor Cell Testing Market Challenges
2.3.4 Circulating Tumor Cell Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell Testing Players by Revenue
3.1.1 Global Top Circulating Tumor Cell Testing Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cell Testing Revenue Market Share by Players (2020-2025)
3.2 Global Top Circulating Tumor Cell Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cell Testing Revenue
3.4 Global Circulating Tumor Cell Testing Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Testing Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cell Testing Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cell Testing, Product and Application
3.7 Global Key Players of Circulating Tumor Cell Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell Testing Breakdown Data by Type
4.1 Global Circulating Tumor Cell Testing Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cell Testing Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cell Testing Breakdown Data by Application
5.1 Global Circulating Tumor Cell Testing Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cell Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cell Testing Market Size (2020-2031)
6.2 North America Circulating Tumor Cell Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cell Testing Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cell Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cell Testing Market Size (2020-2031)
7.2 Europe Circulating Tumor Cell Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cell Testing Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cell Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell Testing Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cell Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cell Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cell Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cell Testing Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cell Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cell Testing Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cell Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell Testing Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cell Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cell Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cell Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Cell Diagnostics, Inc.
11.1.1 Advanced Cell Diagnostics, Inc. Company Details
11.1.2 Advanced Cell Diagnostics, Inc. Business Overview
11.1.3 Advanced Cell Diagnostics, Inc. Circulating Tumor Cell Testing Introduction
11.1.4 Advanced Cell Diagnostics, Inc. Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.1.5 Advanced Cell Diagnostics, Inc. Recent Development
11.2 Aviva Biosciences
11.2.1 Aviva Biosciences Company Details
11.2.2 Aviva Biosciences Business Overview
11.2.3 Aviva Biosciences Circulating Tumor Cell Testing Introduction
11.2.4 Aviva Biosciences Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.2.5 Aviva Biosciences Recent Development
11.3 Cynvenio Biosystems, Inc.
11.3.1 Cynvenio Biosystems, Inc. Company Details
11.3.2 Cynvenio Biosystems, Inc. Business Overview
11.3.3 Cynvenio Biosystems, Inc. Circulating Tumor Cell Testing Introduction
11.3.4 Cynvenio Biosystems, Inc. Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.3.5 Cynvenio Biosystems, Inc. Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Details
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cell Testing Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.4.5 ApoCell Recent Development
11.5 Biocept Inc.
11.5.1 Biocept Inc. Company Details
11.5.2 Biocept Inc. Business Overview
11.5.3 Biocept Inc. Circulating Tumor Cell Testing Introduction
11.5.4 Biocept Inc. Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.5.5 Biocept Inc. Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Circulating Tumor Cell Testing Introduction
11.6.4 Qiagen Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.6.5 Qiagen Recent Development
11.7 MiltenyiBiotec
11.7.1 MiltenyiBiotec Company Details
11.7.2 MiltenyiBiotec Business Overview
11.7.3 MiltenyiBiotec Circulating Tumor Cell Testing Introduction
11.7.4 MiltenyiBiotec Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.7.5 MiltenyiBiotec Recent Development
11.8 Clearbridge Biomedics Pte Ltd
11.8.1 Clearbridge Biomedics Pte Ltd Company Details
11.8.2 Clearbridge Biomedics Pte Ltd Business Overview
11.8.3 Clearbridge Biomedics Pte Ltd Circulating Tumor Cell Testing Introduction
11.8.4 Clearbridge Biomedics Pte Ltd Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.8.5 Clearbridge Biomedics Pte Ltd Recent Development
11.9 Menarini Silicon Biosystems
11.9.1 Menarini Silicon Biosystems Company Details
11.9.2 Menarini Silicon Biosystems Business Overview
11.9.3 Menarini Silicon Biosystems Circulating Tumor Cell Testing Introduction
11.9.4 Menarini Silicon Biosystems Revenue in Circulating Tumor Cell Testing Business (2020-2025)
11.9.5 Menarini Silicon Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Advanced Cell Diagnostics, Inc.
Aviva Biosciences
Cynvenio Biosystems, Inc.
ApoCell
Biocept Inc.
Qiagen
MiltenyiBiotec
Clearbridge Biomedics Pte Ltd
Menarini Silicon Biosystems

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂